Previous Close | 1.2650 |
Open | 1.2800 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 1.2400 - 1.2896 |
52 Week Range | 1.1000 - 7.3300 |
Volume | |
Avg. Volume | 86,179 |
Market Cap | 13.437M |
Beta (5Y Monthly) | 1.25 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
An announcement from NRX Pharmaceuticals ( (NRXP) ) is now available. Stephen Willard resigned abruptly as CEO of NRx Pharmaceuticals to lead a new biotech firm, with Dr. Jonathan Javitt taking over as Interim CEO. The company is actively seeking a new CEO with experience in commercial drug launches. At the Annual Meeting, stockholders elected Class III directors and approved the issuance of common stock, a potential reverse stock split, and the appointment of Salberg & Company, P.A. as independ
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...